Impax Asset Management Group plc Sells 29,585 Shares of Ventas, Inc. $VTR

Key Points

• Impax Asset Management cut its stake in Ventas by 11.8%, selling 29,585 shares and now holding 220,300 shares valued at about $17.05 million.
• Significant insider selling occurred recently: EVP Carey S. Roberts sold 35,532 shares at roughly $85 ($3.02M) and CEO Debra A. Cafaro sold 10,322 shares at about $77.66, leaving insiders with roughly 0.53% ownership.
• Ventas posted a steep quarterly EPS miss ($0.15 vs. $0.89 expected) but gave FY2026 guidance of $3.78–$3.88; analysts maintain a generally positive view with an average target of $90.47 and mostly Buy ratings, and the company raised its quarterly dividend to $0.52 (2.5% yield).

Impax Asset Management Group plc reduced its position in shares of Ventas, Inc. (NYSE:VTR - Free Report) by 11.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 220,300 shares of the real estate investment trust's stock after selling 29,585 shares during the quarter. Impax Asset Management Group plc's holdings in Ventas were worth $17,047,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Sava Infond d.o.o. grew its stake in shares of Ventas by 12.8% during the 4th quarter. Sava Infond d.o.o. now owns 47,885 shares of the real estate investment trust's stock valued at $3,705,000 after purchasing an additional 5,450 shares during the period. Concurrent Investment Advisors LLC bought a new position in shares of Ventas during the 4th quarter valued at approximately $285,000. Copeland Capital Management LLC bought a new position in shares of Ventas during the 4th quarter valued at approximately $238,000. Geneos Wealth Management Inc. grew its stake in shares of Ventas by 44.6% during the 4th quarter. Geneos Wealth Management Inc. now owns 1,913 shares of the real estate investment trust's stock valued at $148,000 after acquiring an additional 590 shares during the period. Finally, Turtle Creek Wealth Advisors LLC grew its stake in shares of Ventas by 26.4% during the 4th quarter. Turtle Creek Wealth Advisors LLC now owns 5,032 shares of the real estate investment trust's stock valued at $389,000 after acquiring an additional 1,051 shares during the period. 94.18% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the transaction, the executive vice president owned 72,755 shares of the company's stock, valued at approximately $6,184,175. This represents a 32.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the transaction, the chief executive officer directly owned 1,114,034 shares in the company, valued at $86,515,880.44. The trade was a 0.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.53% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

VTR has been the subject of a number of recent research reports. Morgan Stanley set a $90.00 price objective on Ventas in a research note on Friday, February 13th. JPMorgan Chase & Co. boosted their price objective on Ventas from $88.00 to $93.00 and gave the company an "overweight" rating in a research note on Friday, March 20th. Royal Bank Of Canada boosted their price target on Ventas from $83.00 to $91.00 and gave the stock an "outperform" rating in a report on Tuesday, February 10th. The Goldman Sachs Group reissued a "buy" rating and issued a $100.00 price target on shares of Ventas in a report on Monday, February 9th. Finally, Citigroup boosted their price target on Ventas from $88.00 to $96.00 and gave the stock a "buy" rating in a report on Wednesday, February 11th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $90.47.

Ventas Stock Performance

NYSE:VTR opened at $83.75 on Friday. The stock's fifty day moving average is $84.70 and its 200 day moving average is $79.51. Ventas, Inc. has a fifty-two week low of $61.76 and a fifty-two week high of $88.36. The firm has a market capitalization of $39.82 billion, a PE ratio of 155.09, a PEG ratio of 2.04 and a beta of 0.75. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67.

Ventas (NYSE:VTR - Get Free Report) last released its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a net margin of 4.31% and a return on equity of 2.09%. The company had revenue of ($1,229.71) million for the quarter, compared to analysts' expectations of $1.53 billion. During the same quarter in the previous year, the company posted $0.81 EPS. The business's quarterly revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, sell-side analysts anticipate that Ventas, Inc. will post 3.85 earnings per share for the current year.

Ventas Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st were paid a $0.52 dividend. The ex-dividend date was Tuesday, March 31st. This is a positive change from Ventas's previous quarterly dividend of $0.48. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Ventas's payout ratio is 385.19%.

Ventas Company Profile

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.